Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/03/24
End: 07/09/24
Due: 07/09/25
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 10/22/23
Due: 10/22/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection | NCT06159062 | Yangshengtang Co., Ltd | user2@example.com | None | 2024-06-03 | 2024-07-09 | 2025-07-09 | - | - | 2025-07-14 |
| Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects | NCT05310487 | Yangshengtang Co., Ltd | user2@example.com | None | 2022-09-30 | 2023-10-22 | 2024-10-22 | - | - | 2025-07-14 |